Abnormal Tr1 differentiation in multiple sclerosis

被引:70
|
作者
Astier, Ame L.
Hafler, David A.
机构
[1] Brigham & Womens Hosp, Ctr Neurol Dis, Lab Mol Immunol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
关键词
multiple sclerosis; Tr1 regulatory T cells; IL-10; CD46;
D O I
10.1016/j.jneuroim.2007.09.018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). In the recent years, accumulating evidence has supported an immunosuppressive role for regulatory T cells (Tregs). Most studies in the context of autoimmunity have focused on the defects of the CD4(+)CD25(high) Tregs. However, we recently demonstrated an altered function of Tr1 Treg cells in MS, characterized by a lack of IL-10 secretion. Therefore, several major regulatory T cell defects are involved in human autoimmune disease. Hence, the induction of Tregs or the stimulation of Treg activity may be beneficial for the treatment of such diseases. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:70 / 78
页数:9
相关论文
共 50 条
  • [1] Acquired regulatory function (Tr1) is impaired in multiple sclerosis patients
    Garcia-Munoz, R
    Inoges, S
    Lopez, A
    Palacios, R
    Sepulcre, J
    Cabello, JP
    Fernandez-Diez, B
    Bendandi, M
    Villoslada, P
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 224 - 224
  • [2] IL-10 suppressor activity and Tr1 cell function are impaired in multiple sclerosis
    Villoslada, Pablo
    Garcia-Munoz, Ricardo
    Inoges, Susana
    Lopez, Ascension
    Palacios, Ricardo
    Sepulcre, Jorge
    Melero, Ignacio
    Bendandi, Maurizio
    NEUROLOGY, 2007, 68 (12) : A396 - A396
  • [3] Differentiation of human type 1 T regulatory (Tr1) cells
    Levings, MK
    Squadrone, S
    Malefyt, RD
    Roncarolo, MG
    FASEB JOURNAL, 2000, 14 (06): : A924 - A924
  • [4] The anthelmintic drug praziquantel promotes human Tr1 differentiation
    Eyoh, Enwono
    McCallum, Patrick
    Killick, Justin
    Amanfo, Seth
    Mutapi, Francisca
    Astier, Anne L.
    IMMUNOLOGY AND CELL BIOLOGY, 2019, 97 (05): : 512 - 518
  • [5] Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis
    Astier, Anne L.
    Meiffren, Gregory
    Freeman, Samuel
    Hafler, David A.
    JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (12): : 3252 - 3257
  • [6] IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis
    Martinez-Forero, Ivan
    Garcia-Munoz, Ricardo
    Martinez-Pasamar, Sara
    Inoges, Susana
    de Cerio, Ascension Lopez-Diaz
    Palacios, Ricardo
    Sepulcre, Jorge
    Moreno, Beatriz
    Gonzalez, Zaira
    Fernandez-Diez, Begona
    Melero, Ignacio
    Bendandi, Maurizio
    Villoslada, Pablo
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (02) : 576 - 586
  • [7] The critical roles of IRF1 and BATF during differentiation of Tr1 cells
    Karwacz, K.
    Miraldi, E.
    Pokrovskii, M.
    Asaf, M.
    Bonneau, R.
    Dan, L.
    Kuchroo, V
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 258 - 258
  • [8] Tr1 cells in allogeneic transplantations
    Bachetta, R.
    Gregori, S.
    Lucarelli, B.
    Battaglia, M.
    Ciceri, F.
    Roncarolo, M. Grazia
    IMMUNOLOGY, 2011, 135 : 9 - 9
  • [9] IRF-1 is a key transcriptional regulator of Tr1 differentiation (P1135)
    Karwacz, Katarzyna
    Yosef, Nir
    Kuchroo, Vijay
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [10] Vitamin D promotes Tr1 differentiation through the CD46 pathway
    Astier, Anne
    Kickler, Karoline
    Choileain, Siobhan Ni
    JOURNAL OF IMMUNOLOGY, 2012, 188